Brean Downgrades United Therapeutics (UTHR) to Hold, Says Price Target Acheived
Brean Capital downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Hold.
"We are downgrading United to Hold from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
"We are downgrading United to Hold from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
